MedPath

南京力成药业有限公司

Ownership
-
Established
2021-05-26
Employees
-
Market Cap
-
Website
https://www.leecan.cc

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Formoterol Fumarate Inhalation Solution

Product Name
富马酸福莫特罗吸入溶液
Approval Number
国药准字H20253077
Approval Date
Jan 8, 2025
NMPA

Bendamustine Hydrochloride for Injection

Product Name
注射用盐酸苯达莫司汀
Approval Number
国药准字H20249779
Approval Date
Dec 25, 2024
NMPA

Bendamustine Hydrochloride for Injection

Product Name
注射用盐酸苯达莫司汀
Approval Number
国药准字H20249778
Approval Date
Dec 25, 2024
NMPA

Compound Ipratropium Bromide Solution for Inhalation

Product Name
吸入用复方异丙托溴铵溶液
Approval Number
国药准字H20249758
Approval Date
Dec 17, 2024
NMPA

Budesonide Suspension for Inhalation

Product Name
吸入用布地奈德混悬液
Approval Number
国药准字H20244102
Approval Date
Jun 18, 2024
NMPA

Salbutamol Sulfate Inhalation Solution

Product Name
吸入用硫酸沙丁胺醇溶液
Approval Number
国药准字H20244093
Approval Date
Jun 18, 2024
NMPA

Terbutaline Sulfate Nebuliser Solution

Product Name
硫酸特布他林雾化吸入用溶液
Approval Number
国药准字H20243490
Approval Date
Apr 11, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.